SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
IDERA PHARMACEUTICALS INC
(NQSC:IDRA Last Sale: 1.82 +0)
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQSC: (IDRA : $1.82)
$55,705 million Market Cap at Market Close, July 1, 2022
Biomedics SubIndustry up .00% / Health Industry up .00% Today

167 Sidney Street Research Report Earnings Snapshot - Last 03/13/18
Cambridge, MA 02139 Fact Sheet
Phone: (617) 679-5500 Financial Statements
Peer Comparison
Annual Reports

Sudhir Agrawal, Pres./CEO, Donna A. Lopilito, Interim CFO
Develops genetic medicines based on antisense technology. IPO at $10 January 24, 1996. Raised $50 MM, selling 5 MM shares, 21% of the outstanding. Lead Manager: Lehman Brothers. Transfer to (Amex: HBY) from (Nasdaq: HYBN) December 2003. Formerly HYBRIDON INC, until September 13, 2005 merger.
Historical Charts    Technical Analysis
No Historical Data available for IDRA

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common IDRA $1.82 $1.82 0 .0 $1.73 $1.85 95,214 $1.73 $1.85 30,607,326
Warrants IDRAW $1.7175 $ 0 $1.7175 $1.7175 25,000 $.83 $1.77 0
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $55,705,333

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
10-DEC-07 IDP Symbol Changed to IDRA
29-JUN-06 IDRA Split 1 for 8
12-SEP-05 HBY Symbol Changed to IDP
05-DEC-03 HYBN Symbol Changed to HBY
12-JAN-98 HYBND Symbol Changed to HYBN
10-DEC-97 HYBN Symbol Changed to HYBND
09-DEC-97 HYBN Split 1 for 5

A312
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex